Personalis (PSNL) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

PSNL Personalis

Watchlist

5.750
+0.490+9.32%

Close Dec 20 16:00 ET

5.900
+0.150+2.61%

Post 19:59 ET

406.23MMarket Cap-3.32P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Personalis (PSNL) Gets a Buy From BTIG
TipRanks05:25 ET · Ratings
Needham Maintains Personalis(PSNL.US) With Buy Rating, Raises Target Price to $7.25
Moomoo NewsDec 20 13:31 ET · Ratings
H.C. Wainwright Maintains Personalis(PSNL.US) With Buy Rating, Raises Target Price to $11
Moomoo NewsDec 20 13:31 ET · Ratings
Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher
BenzingaDec 20 13:05 ET
Strategic Partnerships and Investments Drive Personalis's Growth and Reaffirm Buy Rating
TipRanksDec 20 12:49 ET · Ratings
Mission Produce, Nvidia, Humacyte, BlackBerry And Other Big Stocks Moving Higher On Friday
BenzingaDec 20 10:50 ET

Comments

Jaguar8

Dec 19 17:46

🟢 Watchlist FRIDAY December 20,2024. N F A !

NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
7. I DO NOT give buy or sell advice
8. COH (cash on hand); AH (after hours): RTH (regular trading hours)
$Aadi Biosciences (AADI.US)$ PR AH 12/...

Jaguar8

Dec 19 08:01

NEWS

$Personalis (PSNL.US)$
Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna
Thursday, 19th December at 9:00 am
Personalis, Inc. (NASDAQ: PSNL) announced today agreements with long time collaborators Merck and Moderna that accelerate the advancement of the company's business strategy. The company has received an investment from Merck, known as MSD outside the United States and Canada, and separately has signed a multi-year extension with Mode...

Jaguar8

Dec 16 07:04

NEWS

$Personalis (PSNL.US)$
Personalis and Tempus Expand Collaboration to Biopharma
Monday, 16th December at 8:00 am
Expanded collaboration to yield greater biopharma access to Personalis' MRD solution
Personalis, Inc. (NASDAQ: PSNL) and Tempus AI, Inc. (NASDAQ: TEM) announced today that the companies have expanded their commercial relationship. The companies agreed in November 2023 to collaborate and bring ultra-sensitive MRD testing to market and launched their efforts at the 2024 American Soc...